Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.

[1]  G. Rao,et al.  Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy , 2010, BJU international.

[2]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[3]  V. Tam,et al.  Surveillance and Correlation of Antibiotic Prescription and Resistance of Gram-Negative Bacteria in Singaporean Hospitals , 2010, Antimicrobial Agents and Chemotherapy.

[4]  J. Lorente,et al.  High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. , 2009, Urology.

[5]  R. Paterson,et al.  Bacterial sepsis after prostate biopsy--a new perspective. , 2009, Urology.

[6]  J. Farrar,et al.  High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam , 2009, Journal of medical microbiology.

[7]  M. Liss,et al.  Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. , 2009, Urology.

[8]  R. Honey,et al.  Re: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J. S. Wolf, Jr., C. J. Bennett, R. R. Dmochowski, B. K. Hollenbeck, M. S. Pearle and A. J. Schaeffer. J Urol 2008; 179: 1379-1390. , 2009, The Journal of urology.

[9]  E. Akdeniz,et al.  Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. , 2009, Urology.

[10]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[11]  Shu-Hua Huang,et al.  Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. , 2008, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[12]  R. Kirby,et al.  INFECTIONS AFTER PROSTATE BIOPSY AND ANTIBIOTIC RESISTANCE , 2008, BJU international.

[13]  M. Pearle,et al.  Best practice policy statement on urologic surgery antimicrobial prophylaxis. , 2008, The Journal of urology.

[14]  Michael N. Ferrandino,et al.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? , 2008, The Journal of urology.

[15]  Roberto A Andrade,et al.  Brevundimonas diminuta infections and its resistance to fluoroquinolones. , 2005, The Journal of antimicrobial chemotherapy.

[16]  D. Yong,et al.  Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002. , 2004, Yonsei medical journal.

[17]  J. Baniel,et al.  Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy. , 2003, The Journal of urology.

[18]  D. Kapoor,et al.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. , 1998, Urology.

[19]  J. A. Breslin,et al.  Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. , 1997, The Journal of urology.

[20]  T. Stamey,et al.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. , 1989, The Journal of urology.

[21]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[22]  K. Shigehara,et al.  Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.